Concourse Financial Group Securities’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Hold
0
10479
2023
Q1
Hold
0
10106
2022
Q4
Hold
0
10114
2022
Q3
Hold
0
9924
2022
Q2
Hold
0
9715
2022
Q1
Hold
0
9479
2021
Q4
Hold
0
9075
2021
Q3
Hold
0
8481
2021
Q2
Hold
0
8011
2021
Q1
Hold
0
7600